Over the last decade, various studies have examined the risk of obstetric complications in women using antidepressants during pregnancy.  Preeclampsia:  Some studies have suggested that pregnant women taking SSRI antidepressants may be at higher [...]
 When we provide consultations regarding the use of antidepressants during pregnancy, one of the most difficult questions we have to answer is related to the long-term effects of prenatal antidepressant exposure. Specifically, do antidepressants [...]
We have long been interested in understanding the effects of prenatal exposure to antidepressants on the development of the fetal brain. Â The earliest studies addressing this question were small but yielded detailed (and reassuring) information [...]
The following post was first published in OB/GYN News. Please see our OB/GYN News archives here. Publish date: November 1, 2016 By: Gerald G. Briggs, BPharm, FCCP, Christina Chambers, PhD, MPH, Lee S. Cohen, MD, & Gideon Koren, MD Editor’s note: As [...]
A few days ago, an article was published in the journal Pediatrics on neonatal morbidity observed in children exposed to antidepressants. Â Although this article is likely to find its way into the headlines, it is [...]
Last week, an article looking at the cognitive and motor development of children with prenatal exposure to antidepressants was published in JAMA Psychiatry. Â Since that time, we have received a lot of questions regarding the [...]
Big data is changing the face of medicine, yielding information that may drastically change how we practice medicine. Â In the field of perinatal psychiatry, we are now seeing more and more studies which rely on [...]
 Over the last decade, numerous studies on the reproductive safety of selective serotonin reuptake inhibitors (SSRIs) have been published.  However, these studies, using different methodologies and studying different populations, have often yielded conflicting results. [...]
In 2006, Chambers and colleagues published an article linking selective serotonin reuptake inhibitor (SSRI) antidepressant use during late pregnancy to an increased risk of persistent pulmonary hypertension in the newborn (PPHN). PPHN is a cardiovascular [...]
While we have adequate data to support the use of SSRI antidepressants during pregnancy, there is less data regarding other classes of antidepressants. A new case series documents the outcomes of infants exposed to mirtazapine (Remeron).
